about
Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cellsTNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxiaAdenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer.A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors.Towards the emerging crosstalk: ERBB family and steroid hormones.GSK3β regulates physiological migration of stem/progenitor cells via cytoskeletal rearrangement.Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activationThe key roles of ERBB2 in cardiac regeneration.Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors.Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.Monocytes-macrophages that express α-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow.Neonatal Apex Resection Triggers Cardiomyocyte Proliferation, Neovascularization and Functional Recovery Despite Local Fibrosis.IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypesControl of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculationA Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR TherapyCXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions.Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies.
P50
Q24629061-D9FF2E58-AB11-4A10-8C49-DEBA52703245Q34130168-8367168A-F024-41A9-AFB9-13F20880AF34Q34385041-5D8B6BD2-4D3F-457A-872F-24D410D5A8C4Q35049230-C7721EAF-623A-4093-A765-466D758A8F32Q37124069-AF3597CC-3F4E-497D-BCF1-CC8538F9C2D8Q37687796-E3744B81-2123-46E4-9C64-B78140C65196Q38637973-398BE4A4-252C-4926-A1A4-710EA51FC375Q39498749-C40CA626-A348-4E2A-A05D-1934E4917915Q42321106-71C6D237-4DFE-4D1B-A502-AAAB82EFCE2AQ43207091-B7E59400-617B-4C73-ABC1-0BF7A4767E60Q44823506-F4E16E61-114E-4669-84ED-184C62E3AD00Q49346065-4EED1F57-0079-449C-9D7D-12CFCE502A17Q50992137-A4E43E1C-6088-41DF-A073-3B185C1A1BA1Q54483270-899A636C-BD8E-4983-8166-F29F533BF097Q55022347-BB8F547C-B887-43CE-803E-C65D03EADD89Q56986527-26F45F08-DCBA-4E11-A9E1-E99B0A333A99Q58378734-9505C10B-BE9F-4488-BDA8-95A9DAE401B4Q58693496-252F735A-1CBC-42C6-B1ED-723A70BBBAF4Q64883908-5685CA54-B477-4AEE-A487-91C22449E09CQ64983509-0E3DBB51-A95D-4132-A3B7-99F95088C8C2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gabriele D'Uva
@ast
Gabriele D'Uva
@en
Gabriele D'Uva
@es
Gabriele D'Uva
@nl
Gabriele D'Uva
@sl
type
label
Gabriele D'Uva
@ast
Gabriele D'Uva
@en
Gabriele D'Uva
@es
Gabriele D'Uva
@nl
Gabriele D'Uva
@sl
prefLabel
Gabriele D'Uva
@ast
Gabriele D'Uva
@en
Gabriele D'Uva
@es
Gabriele D'Uva
@nl
Gabriele D'Uva
@sl
P1053
A-6252-2015
P106
P108
P1153
36598176300
P2798
P31
P496
0000-0001-9622-9288